{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:28:11Z","timestamp":1791444491125,"version":"4.3.3"},"reference-count":34,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2013,11,20]]},"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate if esomeprazole prevents recurrent peptic ulcer in adult patients with a history of peptic ulcer receiving low-dose acetylsalicylic acid (ASA, aspirin) for cardiovascular protection in East Asia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective, randomised, double-blind, placebo-controlled trial conducted in Japan, Korea and Taiwan, eligible patients receiving low-dose ASA for cardiovascular protection (81\u2013324\u2005mg\/day) were randomised to esomeprazole 20\u2005mg\/day or placebo for \u226472\u2005weeks. All patients received concomitant mucosal protection (gefarnate 100\u2005mg\/day). The primary endpoint was time to ulcer recurrence (Kaplan\u2013Meier analysis). Efficacy findings are presented up to week 48, as per a planned interim analysis within the study protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 364 patients (79.9% men; mean age, 67.1\u2005years) comprised the full analysis set (esomeprazole, n=182; placebo, n=182). There was a statistically significant difference in the time to ulcer recurrence between esomeprazole and placebo (HR 0.09; 96.65% CI 0.02 to 0.41; p&lt;0.001). The estimated ulcer-free rate at week 12 was 99.3% (esomeprazole) and 89.0% (placebo). The high estimated ulcer-free rate for esomeprazole was maintained through to week 48 (98.3% vs 81.2% of placebo-treated patients). No factors, other than female gender, reduced time to ulcer recurrence in addition to the effect of esomeprazole (p&lt;0.001). Treatment with esomeprazole was generally well tolerated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Daily esomeprazole 20\u2005mg is efficacious and well tolerated in reducing the recurrence of peptic ulcer in East-Asian patients with a history of ulcers who are taking low-dose ASA for cardiovascular protection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>ClinicalTrial.gov identifier<\/jats:title>\n                    <jats:p>NCT01069939.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2013-304722","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T22:47:58Z","timestamp":1386715678000},"page":"1061-1068","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":56,"title":["Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study"],"prefix":"10.1136","volume":"63","clinical-trial-number":[{"clinical-trial-number":"nct01069939","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00441727","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kentaro","family":"Sugano","sequence":"first","affiliation":[{"name":"Department of Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Gyu","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Town","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Medicine, E-Da Hospital, Kaohsiung and Fu Jen Catholic University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Goto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Shimane University School of Medicine, Shimane, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Miwa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chern-En","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Medical Research and Education, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Chiba","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Hori","sequence":"additional","affiliation":[{"name":"Osaka Medical Center, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo-Eki Center-building Clinic, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Yonsei University Wonju College of Medicine, Wonju Christian Hospital, Wonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yang","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, E-Da Hospital and I-Shou University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Date","sequence":"additional","affiliation":[{"name":"Research & Development, AstraZeneca, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the LAVENDER Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,12,10]]},"reference":[{"key":"2025121221133150000_63.7.1061.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318235eb4d"},{"key":"2025121221133150000_63.7.1061.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs092"},{"key":"2025121221133150000_63.7.1061.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02649.x"},{"key":"2025121221133150000_63.7.1061.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.10.027"},{"key":"2025121221133150000_63.7.1061.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6983.827"},{"key":"2025121221133150000_63.7.1061.6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01355.x"},{"key":"2025121221133150000_63.7.1061.7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.080754"},{"key":"2025121221133150000_63.7.1061.8","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181580e8a"},{"key":"2025121221133150000_63.7.1061.9","doi-asserted-by":"publisher","DOI":"10.2165\/11589200-000000000-00000"},{"key":"2025121221133150000_63.7.1061.10","doi-asserted-by":"publisher","DOI":"10.2165\/11318440-000000000-00000"},{"key":"2025121221133150000_63.7.1061.11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31820d62b5"},{"key":"2025121221133150000_63.7.1061.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4094"},{"key":"2025121221133150000_63.7.1061.13","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.445"},{"key":"2025121221133150000_63.7.1061.14","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.217547"},{"key":"2025121221133150000_63.7.1061.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01995.x"},{"key":"2025121221133150000_63.7.1061.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-011-0397-7"},{"key":"2025121221133150000_63.7.1061.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0588-x"},{"key":"2025121221133150000_63.7.1061.18","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.DMPK-11-RV-111"},{"key":"2025121221133150000_63.7.1061.19","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199529030-00005"},{"key":"2025121221133150000_63.7.1061.20","unstructured":"Greenwood M . The errors of sampling of the survivorship tables . Reports on Public Health and Statistical Subjects. 1926. London: HMSO."},{"key":"2025121221133150000_63.7.1061.21","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E"},{"key":"2025121221133150000_63.7.1061.22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01230.x"},{"key":"2025121221133150000_63.7.1061.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04415.x"},{"key":"2025121221133150000_63.7.1061.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0598-8"},{"key":"2025121221133150000_63.7.1061.25","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X162656"},{"key":"2025121221133150000_63.7.1061.26","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(84)90371-6"},{"key":"2025121221133150000_63.7.1061.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04038.x"},{"key":"2025121221133150000_63.7.1061.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d2690"},{"key":"2025121221133150000_63.7.1061.29","doi-asserted-by":"publisher","DOI":"10.5414\/CPP47564"},{"key":"2025121221133150000_63.7.1061.30","first-page":"217","article-title":"Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers","volume":"12","author":"Andersson","year":"2012","journal-title":"Am J Cardiovasc Drugs"},{"key":"2025121221133150000_63.7.1061.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.01.007"},{"key":"2025121221133150000_63.7.1061.32","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.092129"},{"key":"2025121221133150000_63.7.1061.33","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.1.22"},{"key":"2025121221133150000_63.7.1061.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02441.x"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2013-304722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:13:41Z","timestamp":1765602821000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2013-304722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,10]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,6,6]]},"published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1136\/gutjnl-2013-304722"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2013-304722","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,10]]}}}